Abeona Therapeutics (NASDAQ:ABEO) Now Covered by Analysts at Oppenheimer
Equities research analysts at Oppenheimer began coverage on shares of Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $16.00 price target on the biopharmaceutical company’s stock. Oppenheimer’s target price would suggest a potential upside of 201.89% from the company’s current […]
Equities research analysts at Oppenheimer began coverage on shares of Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $16.00 price target on the biopharmaceutical company’s stock. Oppenheimer’s target price would suggest a potential upside of 201.89% from the company’s current […]
